homocystinuria due to methylene tetrahydrofolate reductase deficiency
MONDO:0009353
Homocystinuria due to methylene tetrahydrofolate reductase (MTHFR) deficiency is a metabolic disorder characterized by neurological manifestations.
Outbreak surveillance
Global reported eventsExplore recent public health notices potentially related to homocystinuria due to methylene tetrahydrofolate reductase deficiency. Results are keyword matches, not yet verified disease-to-outbreak relationships.
View homocystinuria due to methylene tetrahydrofolate reductase deficiency on the outbreak map →Methylenetetrahydrofolate reductase deficiency
Methylenetetrahydrofolate reductase deficiency is the most common genetic cause of elevated serum levels of homocysteine (hyperhomocysteinemia). It is caused by genetic defects in MTHFR, which is an important enzyme in the methyl cycle. Common variants of MTHFR deficiency are asymptomatic and have only minor effects on disease risk. Severe variants (from nonsense mutations) are rare.
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
1 shownDrugs being studied
Research locations
Leading sponsors
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.